Development and preclinical assessment of a bioartificial pancreas

Swiss Medical Weekly

Volumn 137, Issue SUPPL. 155, 2007, Pages

  Thorens, Bernard ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Beta cells; Diabetes; Genetic engineering; Immunoprotection; Transplantation

Indexed keywords

FLICE INHIBITORY PROTEIN; GAMMA INTERFERON; INSULIN; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BCL 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTIFICIAL PANCREAS; AUTOIMMUNE DISEASE; BIOARTIFICIAL ORGAN; CELL CLONING; CELL FUNCTION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; GENE EXPRESSION; GENE TRANSFER; GENETIC ENGINEERING; HYPERGLYCEMIA; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

EID: 34249328481     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Efrat S, Fusco-DeMane D, Lemberg H, Al Emran O, Wang W. Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci. USA 1995;92:3576-80.
2. Dupraz P, Rinsch C, Pralong WF, Rolland E, Zufferey R, Trono D, et al. Lentivirus-mediated Bcl-2 expression in βTc-Tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Therapy. 1999;6:1160-9.
3. Burns K, Marinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 1998;273:12203-9.
4. Dupraz P, Cottet S, Hamburger F, Dolci W, Felley-Bosco E, Thorens B. Dominant-negative Myd88 proteins inhibit IL-IB/IFN-γ-mediated induction of nuclear factor κ-dependent nitrite production and apoptosis in β cells. J Biol Chem. 2000;275:37672-8.
5. Pestka S, Kotenko SV, Muthukumaran G, Izotova LS, Cook JR, Garotta G. The interferon gamma (IFN-γ) receptor: a paradigm for the multichain cytokine receptor. Cytokine & Growth Factor Review 1997;8:189-206.
6. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Ann Rev Immunol. 2000;18:143-64.
7. Cottet S, Dupraz P, Hamburger F, Dolci W, Jaquet M, Thorens B. SOCS-1 protein prevents janus kinase/STAT-dependent inhibition of β cell insulin gene transcription and secretion in response to interferon-gamma. J Biol Chem. 2001;276:25862-70.
8. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, et al. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190-5.
9. Thome M, Schneider P, Hofman, Fickensche H, Meini E, Neipel F, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 1997;386:517-21.
10. Cattan P, Rottembourg D, Cottet S, Tardivel I, Dupraz P, Thorens B, et al. Destruction of conditional insulinoma cell lines in NOD mice: A role for autoimmunity. Diabetologia. 2003;46:504-10.
11. Pericin M, Althage A, Freigang S, Hengartner H, Rolland E, Dupraz P, et al. Allogeneic β-islet cells correct diabetes and resist immune rejection. 2002;9:8203-6.